» Articles » PMID: 24453417

Erythrocyte Shape Abnormalities, Membrane Oxidative Damage, and β-actin Alterations: an Unrecognized Triad in Classical Autism

Abstract

Autism spectrum disorders (ASDs) are a complex group of neurodevelopment disorders steadily rising in frequency and treatment refractory, where the search for biological markers is of paramount importance. Although red blood cells (RBCs) membrane lipidomics and rheological variables have been reported to be altered, with some suggestions indicating an increased lipid peroxidation in the erythrocyte membrane, to date no information exists on how the oxidative membrane damage may affect cytoskeletal membrane proteins and, ultimately, RBCs shape in autism. Here, we investigated RBC morphology by scanning electron microscopy in patients with classical autism, that is, the predominant ASDs phenotype (age range: 6-26 years), nonautistic neurodevelopmental disorders (i.e., "positive controls"), and healthy controls (i.e., "negative controls"). A high percentage of altered RBCs shapes, predominantly elliptocytes, was observed in autistic patients, but not in both control groups. The RBCs altered morphology in autistic subjects was related to increased erythrocyte membrane F2-isoprostanes and 4-hydroxynonenal protein adducts. In addition, an oxidative damage of the erythrocyte membrane β-actin protein was evidenced. Therefore, the combination of erythrocyte shape abnormalities, erythrocyte membrane oxidative damage, and β-actin alterations constitutes a previously unrecognized triad in classical autism and provides new biological markers in the diagnostic workup of ASDs.

Citing Articles

Examining Erythrocytes as Potential Blood Biomarkers for Autism Spectrum Disorder: Their Relationship to Symptom Severity and Adaptive Behavior.

Jasenovec T, Radosinska D, Belica I, Raskova B, Puzserova A, Vrbjar N Biomedicines. 2024; 12(11).

PMID: 39595183 PMC: 11591841. DOI: 10.3390/biomedicines12112619.


Clinical Features and Novel Pathogenic Variants of Chinese Patients With McLeod Syndrome and Chorea-Acanthocytosis.

Yu H, Li L, Li X, Liu H Mol Genet Genomic Med. 2024; 12(9):e70015.

PMID: 39324427 PMC: 11425086. DOI: 10.1002/mgg3.70015.


Seeing beyond words: Visualizing autism spectrum disorder biomarker insights.

Xie X, Zhou R, Fang Z, Zhang Y, Wang Q, Liu X Heliyon. 2024; 10(9):e30420.

PMID: 38694128 PMC: 11061761. DOI: 10.1016/j.heliyon.2024.e30420.


Exploring unconventional attributes of red blood cells and their potential applications in biomedicine.

Anastasiadi A, Arvaniti V, Hudson K, Kriebardis A, Stathopoulos C, DAlessandro A Protein Cell. 2024; 15(5):315-330.

PMID: 38270470 PMC: 11074998. DOI: 10.1093/procel/pwae001.


Alterations in Antioxidant Status and Erythrocyte Properties in Children with Autism Spectrum Disorder.

Jasenovec T, Radosinska D, Jansakova K, Kopcikova M, Tomova A, Snurikova D Antioxidants (Basel). 2023; 12(12).

PMID: 38136174 PMC: 10741171. DOI: 10.3390/antiox12122054.


References
1.
Villagonzalo K, Dodd S, Dean O, Gray K, Tonge B, Berk M . Oxidative pathways as a drug target for the treatment of autism. Expert Opin Ther Targets. 2010; 14(12):1301-10. DOI: 10.1517/14728222.2010.528394. View

2.
Miyake K, Hirasawa T, Koide T, Kubota T . Epigenetics in autism and other neurodevelopmental diseases. Adv Exp Med Biol. 2012; 724:91-8. DOI: 10.1007/978-1-4614-0653-2_7. View

3.
Laszlo A, Novak Z, Szollosi-Varga I, Hai D, Vetro A, Kovacs A . Blood lipid peroxidation, antioxidant enzyme activities and hemorheological changes in autistic children. Ideggyogy Sz. 2013; 66(1-2):23-8. View

4.
Ciccoli L, Signorini C, Alessandrini C, Ferrali M, Comporti M . Iron release, lipid peroxidation, and morphological alterations of erythrocytes exposed to acrolein and phenylhydrazine. Exp Mol Pathol. 1994; 60(2):108-18. DOI: 10.1006/exmp.1994.1010. View

5.
Herguner S, Kelesoglu F, Tanidir C, Copur M . Ferritin and iron levels in children with autistic disorder. Eur J Pediatr. 2011; 171(1):143-6. DOI: 10.1007/s00431-011-1506-6. View